MK

Manvitha Koluguri

Active Director Additional Director DIN 10825677
DIN 10825677 First appointment Nov 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Manvitha Koluguri

Data last updated:

Manvitha Koluguri is an Additional Director at Cenote Life Sciences Private Limited (since 2024). The company operates in Paper.

DIN 10825677
Primary Designation Additional Director
Industry Paper
First Appointment 04 Nov 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cenote Life Sciences Private Limited U21001TS2024PTC185429
Additional Director04 Nov 20242024Active

Board colleagues of Manvitha Koluguri

Directorship timeline

Open interactive timeline →
Cenote Life Sciences Private Limited
Premium access

Shareholding and investment profile for Manvitha Koluguri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manvitha Koluguri

Manvitha Koluguri currently holds 1 directorship: Cenote Life Sciences Private Limited (Additional Director, since 04 Nov 2024).

Manvitha Koluguri was first appointed on 04 Nov 2024 as Additional Director at Cenote Life Sciences Private Limited.

The current boards of Manvitha Koluguri's companies include Avula Sushma Reddy (Cenote Life Sciences Private Limited), Sudhakara Reddy Kotapati (Cenote Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available